Illumina Inc ILMN

NAS: ILMN | ISIN: US4523271090 17/04/2026

134,50 USD (+1,34%)

(+1,34%) 17/04/2026

Grafiek Illumina Inc

Grafiek Illumina Inc

1 dag1d 1,34%
1 week1w 5,94%
1 maand1m 6,25%
3 maanden3m -8,61%
6 maanden6m 35,18%
1 jaar1j 86,81%
5 jaar5j -66,72%

donderdag 30 april 2026, 22:00

Kwartaalcijfers (1ste kwartaal)

Illumina Inc in het nieuws

Toon enkel gratis nieuws

14 april 2026 · Illumina and the Center for Data-Driven Discovery in Biomedicine bring genomic data and scalable software to the fight against pediatric cancer and rare disease · Persbericht

9 april 2026 · Illumina to Announce First Quarter 2026 Financial Results on Thursday, April 30, 2026 · Persbericht

2 april 2026 · Illumina Announces Changes to Board of Directors · Persbericht

18 maart 2026 · Illumina and Labcorp expand collaboration to broaden access to precision oncology testing · Persbericht

16 maart 2026 · Illumina advances preventive genomics through strategic consortium with Veritas Genetics · Persbericht

5 maart 2026 · Alliance for Genomic Discovery expands with Regeneron Genetics Center membership and new proteomics data offering · Persbericht

27 februari 2026 · Illumina whole-genome sequencing technology to accelerate rare disease testing in Florida · Persbericht

25 februari 2026 · Illumina partners go beyond the genome, driving cancer breakthroughs using spatial transcriptomics, epigenomics, and proteomics · Persbericht

24 februari 2026 · Illumina launches TruPath Genome, setting a new standard in genomic insight · Persbericht

23 februari 2026 · Illumina unveils roadmap of groundbreaking NovaSeq X advancements in data quality, output, speed, and flexibility · Persbericht

Profiel Illumina Inc

Gezondheidstechnologie

Productie van analytische laboratoriuminstrumenten

Website: www.illumina.com

Hoofdzetel: San Diego, California Verenigde Staten

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe